Abstract #0136

Can anti-VEGF Antibody Reverse Radiation Necrosis? A Preclinical Investigation

Chong Duan¹, Carlos J Perez-Torres², Liya Yuan³, John A Engelbach⁴, Christina T Tsien⁵, Keith M Rich^3,5, Robert E Schmidt⁶, Joseph JH Ackerman^1,4,7,8, and Joel R Garbow^4,8

¹Chemistry, Washington University in St. Louis, St. Louis, MO, United States, ²Radiological Health Sciences, Purdue University, West Lafayette, IN, United States, ³Neurosurgery, Washington University in St. Louis, St. Louis, MO, United States, ⁴Radiology, Washington University in St. Louis, St. Louis, MO, United States, ⁵Radiation Oncology, Washington University in St. Louis, St. Louis, MO, United States, ⁶Neuropathology, Washington University in St. Louis, St. Louis, MO, United States, ⁷Medicine, Washington University in St. Louis, St. Louis, MO, United States, ⁸Alvin J Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, United States

Recently, radiation necrosis (RN) has been treated clinically using bevacizumab, an anti-VEGF antibody. While bevacizumab reduces radiographic RN volume, the treatment has potentially serious complications and rebound phenomena after the discontinuation of the therapy. In the present study, we investigated the anti-VEGF treatment of pure radiation necrosis in a mouse model. Favorable radiographic appearance of RN were observed following the anti-VEGF treatment. However, the lesions were not completely resolved histologically (e.g., focal mineral deposits were observed in the treated mice). In addition, despite the treatment, VEGF and HIF-1α were still upregulated, which presents the potential risk of recurrence of RN.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.